Kurzübersicht für Four and A Half LIM Domains 3 (FHL3) Peptid (ABIN976854)
Target
FHL3
(Four and A Half LIM Domains 3 (FHL3))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-FHL3 antibody (Catalog #: ARP50498_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
FHL3
Reaktivität: Human, Maus, Ratte
Wirt: Synthetic
BP, BI
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
FHL3
(Four and A Half LIM Domains 3 (FHL3))
Hintergrund
FHL3 contains 4 LIM zinc-binding domains. It is expressed only in skeletal muscle. FHL3 association with MyoD may contribute to the regulation of MyoD-dependent transcription of muscle genes and thereby myogenesis.LIM proteins are defined by the possession of a highly conserved double zinc finger motif called the LIM domain.[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: MGC19547, MGC23614, MGC8696, SLIM2
Protein Interaction Partner: SRF,ACTB,ADAMTSL4,AIMP2,CDC25B,CDC42EP1,CTBP2,FHL2,FHL3,ITGA7,KLF8,LASP1,LNX1,MAPK1,MED15,MZF1,PAK7,PHC2,RBM42,RFX6,SRF,TRIP6,ADAMTSL4,AIMP2,CDC42EP1,CREB1,CTBP2,FHL2,FHL3,FHL5,ITGA7,KLF3,LASP1,LNX1,MED15,PAK7,PHC2,RBM42,RFX6,TRIP6,ZBTB16